Class IIReported 2025-05-07

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

Recalled by Preferred Pharmaceuticals, Inc.

Reason for Recall

cGMP Deviations

Recall Number

D-0391-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-04-18

Reported

2025-05-07

Distribution

Nationwide in the US

Code Info

Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.